European Union fines biotech giant Illumina $475 million for taking over cancer-screening company Grail without approval
BRUSSELS — European Union fines biotech giant Illumina $475 million for taking over cancer-screening company Grail without approval.
24/7 coverage of breaking news and live events
Read more on abcnews.go.com